A20 Regulation of NF-{kappa}B: Perspectives for Inflammatory Lung Disease.
Data(s) |
01/06/2011
|
---|---|
Resumo |
Persistent activation of NF-B is central to the pathogenesis of many inflammatory lung disorders including Cystic Fibrosis, Asthma and Chronic Obstructive Pulmonary Disease. A20 is an endogenous negative regulator of NF-B signalling which has been widely described in autoimmune and inflammatory disorders including Diabetes and Crohn’s disease, but which has received little attention in terms of chronic lung disorders. This review examines the existing body of research on A20 regulation of NF-B signalling and details the mechanism and regulation of A20 action focusing, where possible, on pulmonary inflammation. A20 and its associated signalling molecules are highlighted as being of potential therapeutic interest for the treatment of inflammatory disorders and a proposed model of A20 activity in inflammatory lung disease is provided. |
Formato |
application/pdf |
Identificador | |
Idioma(s) |
eng |
Direitos |
info:eu-repo/semantics/restrictedAccess |
Fonte |
Kelly , C , Shields , M , Elborn , S & Schock , B 2011 , ' A20 Regulation of NF-{kappa}B: Perspectives for Inflammatory Lung Disease. ' American Journal of Respiratory Cell and Molecular Biology , vol in press , no. 6 , pp. 743-748 . DOI: 10.1165/rcmb.2010-0339TR |
Palavras-Chave | #/dk/atira/pure/subjectarea/asjc/1300/1307 #Cell Biology #/dk/atira/pure/subjectarea/asjc/2700/2740 #Pulmonary and Respiratory Medicine #/dk/atira/pure/subjectarea/asjc/1300/1312 #Molecular Biology #/dk/atira/pure/subjectarea/asjc/1300/1308 #Clinical Biochemistry |
Tipo |
article |